Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ortho-Clinical Diagnostics and Caprion to develop vCJD (variant Creutzfeldt Jakob disease) blood test:

This article was originally published in Clinica

Executive Summary

Ortho-Clinical Diagnostics (OCD) has formed a research collaboration with Caprion Pharmaceuticals to develop a blood test for new variant Creutzfeldt-Jacob disease (vCJD). OCD, of Raritan, New Jersey, has taken a option to license Caprion's prion technologies, including the company's panel of monoclonal antibodies for detecting a structural epitope unique to vCJD. A spokesman from Caprion told Clinica that data supporting the antibodies' accuracy are due to be published in a peer review journal.

Topics

UsernamePublicRestriction

Register

MT070729

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel